IL280822A - Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain - Google Patents

Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain

Info

Publication number
IL280822A
IL280822A IL280822A IL28082221A IL280822A IL 280822 A IL280822 A IL 280822A IL 280822 A IL280822 A IL 280822A IL 28082221 A IL28082221 A IL 28082221A IL 280822 A IL280822 A IL 280822A
Authority
IL
Israel
Prior art keywords
acetaminophen
methods
pharmaceutical preparations
treating pain
sebacoyl dinalbuphine
Prior art date
Application number
IL280822A
Other languages
Hebrew (he)
Original Assignee
Jacob Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacob Biotech Ltd filed Critical Jacob Biotech Ltd
Publication of IL280822A publication Critical patent/IL280822A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL280822A 2018-09-03 2021-02-11 Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain IL280822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/103786 WO2020047703A1 (en) 2018-09-03 2018-09-03 Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain

Publications (1)

Publication Number Publication Date
IL280822A true IL280822A (en) 2021-04-29

Family

ID=69721971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL280822A IL280822A (en) 2018-09-03 2021-02-11 Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain

Country Status (11)

Country Link
EP (1) EP3846815A4 (en)
JP (2) JP7318987B2 (en)
KR (1) KR20210054560A (en)
CN (1) CN113164469A (en)
AU (1) AU2018440280B2 (en)
CA (1) CA3111271A1 (en)
CL (1) CL2021000309A1 (en)
IL (1) IL280822A (en)
SG (1) SG11202101974WA (en)
WO (1) WO2020047703A1 (en)
ZA (1) ZA202102209B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US6225321B1 (en) * 1997-06-05 2001-05-01 Oliver Yoa-Pu Hu Long analgesic acting nalbuphine polyester derivative and method of use
WO2004054511A2 (en) * 2002-12-13 2004-07-01 The Regents Of The University Of California Analgesic combination comprising nalbuphine
EP1964552B1 (en) * 2007-03-02 2009-08-26 Flamek Corp OÜ Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids
CN111904924A (en) 2013-11-13 2020-11-10 财团法人国际教育基金会 Application of compound in reducing hepatotoxicity caused by acetaminophen and compound composition

Also Published As

Publication number Publication date
JP2023078480A (en) 2023-06-06
KR20210054560A (en) 2021-05-13
JP7318987B2 (en) 2023-08-01
WO2020047703A1 (en) 2020-03-12
EP3846815A1 (en) 2021-07-14
CL2021000309A1 (en) 2021-07-19
EP3846815A4 (en) 2022-05-04
JP2021535216A (en) 2021-12-16
CA3111271A1 (en) 2020-03-12
CN113164469A (en) 2021-07-23
ZA202102209B (en) 2022-03-30
AU2018440280B2 (en) 2022-11-03
SG11202101974WA (en) 2021-03-30
AU2018440280A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
IL262416A (en) Materials and methods for treatment of hemoglobinopathies
IL277234A (en) Systems and methods for the treatment of hemoglobinopathies
EP3681479A4 (en) Method of administration and treatment
IL275777A (en) Improved peptide pharmaceuticals for treatment of nash and other disorders
EP3749344A4 (en) Methods for therapeutic use of exosomes and y-rnas
EP3682884A4 (en) Crystal form of gsk1278863 and preparation method and pharmaceutical use thereof
EP3991173A4 (en) Systems and methods for prescription and dosing of therapeutic stimuli using recorded guarantees
ZA202007602B (en) Applicator and system for pharmaceutical preparation and method of use
IL272036A (en) Methods and compositions for treatment of pain using capsaicin
EP3891175A4 (en) Modified proteins and associated methods of treatment
IL285647A (en) Material and system for the therapeutic treatment of joints
SG11202112129SA (en) Drug conjugates and methods of using same
IL288531A (en) Wide-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same
HK1257585A1 (en) Medicine for preventing and treating skin fibrosis and use of the medicine
IL277150A (en) Devices for injecting medicaments and methods of use
EP3570835A4 (en) Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders
EP3691748A4 (en) Acetaminophen-pregabalin combinations and methods of treating pain
IL283281A (en) Formulation of contrast media and process of preparation thereof
EP3777849A4 (en) Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain
EP3468540A4 (en) Pharmaceutical compositions and methods for treatment of pain
EP3525787A4 (en) Methods of treatment and pharmaceutical compositions using bcn057 or bcn512
ZA202102209B (en) Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain
EP4034130A4 (en) Pharmaceutical compounds and methods of use
IL271727A (en) Method of treatment and dosage forms thereof
AU2017904756A0 (en) Pharmaceutical combinations and methods of treatment